🇺🇸 placebo tablet of DLBS1033 in United States

placebo tablet of DLBS1033 (placebo tablet of DLBS1033) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

placebo tablet of DLBS1033 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is placebo tablet of DLBS1033 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for placebo tablet of DLBS1033 in United States?

Dexa Medica Group is the originator. The local marketing authorisation holder may differ — check the official source linked above.